Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Dalkilic, A. Articles by Woods, S. W. Search for Related Content PubMed Citation Articles by Dalkilic, A. Articles by Woods, S. W. Bipolar Disorder Anticonvulsants Lithium

Effects of Divalproex Versus Lithium on Length of Hospital Stay Among Patients With Bipolar Disorder

The medical records of all inpatients with bipolar disorder at the Connecticut Mental Health Center in 1997 were examined to compare length of stay for patients who began monotherapy with divalproex (27 treatment starts) and lithium (20 treatment starts). No statistically significant difference was found in length of stay (11.5±6.9 and 10.3±5.2 days for patients on divalproex and lithium, respectively) or other length-of-stay variables. Demographic variables, diagnostic variables, and dosages of neuroleptics and benzodiazepines used adjunctively were similar as well. Dosages and blood levels for divalproex and lithium were consistent with practice guidelines. Prospective randomized studies are needed to compare the cost-effectiveness of divalproex and of lithium in the treatment of bipolar disorder.

This article has been cited by other articles:

				D. J Muzina Divalproex and lithium are similarly cost effective for adults with bipolar disorder Evid. Based Ment. Health, February 1, 2006; 9(1): 15 - 15. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us